Gilead Sciences Inc (GILD)
92.57
+1.48
(+1.62%)
USD |
NASDAQ |
Dec 20, 16:00
92.57
0.00 (0.00%)
After-Hours: 20:00
Gilead Sciences Debt to Equity Ratio: 1.258 for Sept. 30, 2024
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Pfizer Inc | 0.7219 |
Eli Lilly and Co | 2.185 |
Merck & Co Inc | 0.8568 |
AbbVie Inc | 11.78 |
Amgen Inc | 8.024 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 54.52B |
Total Liabilities (Quarterly) | 36.14B |
Shareholders Equity (Quarterly) | 18.47B |
Current Ratio | 1.261 |
Net Debt Paydown Yield | 0.38% |